about
S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motilityDifferential localization of VE- and N-cadherins in human endothelial cells: VE-cadherin competes with N-cadherin for junctional localizationGalectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation.New 1H-pyrazole-containing polyamine receptors able to complex L-glutamate in water at physiological pH values.The component helminth community in six sympatric species of Ardeidae.Hydrogen-bond-mediated self-assembly of 26-membered diaza tetraester crowns of 3,5-disubstituted 1H-pyrazole. Dimerization study in the solid state and in CDCl3 solution.Selected wild strains of Agaricus bisporus produce high yields of mushrooms at 25°C.VE-cadherin expression and clustering maintain low levels of survivin in endothelial cells.Altered AKT1 and MAPK1 gene expression on peripheral blood mononuclear cells and correlation with T-helper-transcription factors in systemic lupus erythematosus patientsA proteomic approach to the identification of new tPA receptors in pancreatic cancer cells.Snail1 is required for the maintenance of the pancreatic acinar phenotype.Pancreatic ductal adenocarcinoma: cellular origin, signaling pathways and stroma contribution.Vegetable and Fruit Intakes Are Associated with hs-CRP Levels in Pre-Pubertal Girls.Pancreatic ductal adenocarcinoma and transcription factors: role of c-Myc.Poly(ADP-Ribose) Polymerases: New Players in the Pathogenesis of Exocrine Pancreatic Diseases.Sequential Functions of CPEB1 and CPEB4 Regulate Pathologic Expression of Vascular Endothelial Growth Factor and Angiogenesis in Chronic Liver Disease.Intraductal delivery of adenoviruses targets pancreatic tumors in transgenic Ela-myc mice and orthotopic xenograftsKey contribution of CPEB4-mediated translational control to cancer progression.The pancreatic niche inhibits the effectiveness of sunitinib treatment of pancreatic cancer.Synthesis and cytotoxic activity of a new potential DNA bisintercalator: 1,4-Bis{3-[N-(4-chlorobenzo[g]phthalazin-1-yl)aminopropyl]}piperazine.Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer.Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2.Sex-related differences in the association of ghrelin levels with obesity in adolescents.Translational reprogramming in tumour cells can generate oncoselectivity in viral therapies.Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation.Nontuberculous mycobacteria infection after mesotherapy: preliminary report of 15 cases.A novel translational control mechanism involving RNA structures within coding sequences.The leukocyte activation receptor CD69 controls T cell differentiation through its interaction with galectin-1.New insights into the tPA-annexin A2 interaction. Is annexin A2 CYS8 the sole requirement for this association?Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains.Relationship of high leptin levels with an adverse lipid and insulin profile in 6-8 year-old children in Spain.Suppression of the metastatic phenotype of a mouse skin carcinoma cell line independent of E-cadherin expression and correlated with reduced Ha-ras oncogene products.Prognostic impact of CD133 expression in Endometrial Cancer Patients.Intercellular junctions in the endothelium and the control of vascular permeability.Expression of alpha 6 beta 4 integrin increases during malignant conversion of mouse epidermal keratinocytes: association of beta 4 subunit to the cytokeratin fraction.Targeting Galectin-1 in pancreatic cancer: immune surveillance on guard.Corrigendum: A novel translational control mechanism involving RNA structures within coding sequences.Zn(II)-coordination and fluorescence studies of a new polyazamacrocycle incorporating 1H-pyrazole and naphthalene units.Selective electrochemical discrimination between dopamine and phenethylamine-derived psychotropic drugs using electrodes modified with an acyclic receptor containing two terminal 3-alkoxy-5-nitroindazole rings.In vitro leishmanicidal activity of imidazole- or pyrazole-based benzo[g]phthalazine derivatives against Leishmania infantum and Leishmania braziliensis species.
P50
Q24311937-8139E544-8BD2-4D00-8A33-10745E56A367Q24683420-82FAB3B6-2F66-4C52-B87D-22F45CD8FA32Q30620697-A723BEC3-3C84-45A5-A42F-8ED90DBC642BQ30888867-4ECA0A25-43B4-4940-A56A-60E040BD667DQ33262891-DF4121A7-9787-45EE-94A2-1B5FCB35765BQ34016924-06EE5C57-6429-446B-8AB2-CD84BE76D71FQ34786729-CBBEA184-8D99-4D97-AD3F-26C7279F95BCQ35102828-5F581DAF-73AB-4903-9398-65B1ED3A12E9Q36355671-3263CC28-20DE-436F-A47E-0B991A4C20F3Q36424099-2A1F72CA-E357-4501-B3AF-04E9DB84C4ADQ36782482-BE623077-6F78-45F8-8213-48045750B5A2Q37250924-90F798BE-4EBE-4134-B558-31C5C10E219CQ37729686-AEA59AB9-C4D8-4F2B-A888-AB099851B177Q37833539-947D3E1C-6C25-498F-997A-97E6E44F1779Q38674736-736BFCF3-8DFF-47BD-8F7B-7B04DFC4F553Q38815138-7AB5C710-C0C7-4B98-B810-FA68035E6208Q39208944-2E834CB2-C82D-405E-9170-DC6842FA2581Q39433508-4F9652E6-4481-4606-AF5C-E60B84E5CF0FQ39635470-610D59A0-EBD2-4607-A88D-3946A2C6DD1FQ39694645-073EB021-F27A-438F-8158-9FE074BD04E2Q39890623-1C51714B-4163-4240-889A-EF69D2BCAF86Q40141648-81490F50-8962-4C27-976B-3DC8C380CEB2Q40180244-CC7E4C09-4DF3-45F8-AD6B-C3E4A5AB7B12Q40289834-0E2CB5F0-1DD7-4EAE-A301-34420DD13A28Q40429251-8BCCEECA-B87D-4FF9-A522-CAECB9A9EC51Q40448125-DF525F89-0563-4463-BF0D-2AB576063ACCQ40467508-D387DCF3-A2B3-4252-97E3-271732921878Q40604074-79115565-2D6E-4226-9184-39F2549FC6BCQ40685194-D5E8D0CF-0287-42C6-A275-B9E432FDF670Q41011680-0CBED5D7-0A1F-4CEA-8306-F15CCF889CCEQ41094333-CDFBB8CF-515F-4A6C-AE88-D62CC322127FQ41235120-7D16D024-CF41-4A29-99F7-71D8269DB2EAQ41332330-F5BFBF7A-D2B4-4EB9-973D-DA5D41791560Q41500519-815224EE-4970-467A-AE1C-986860CE590FQ41611433-717332E5-5BAB-4E07-81FA-DF3B6E56F7EEQ42030543-F8707CD9-21DA-4B20-B496-71D9E0389E4FQ42292984-2EE2DF27-D309-47FE-9ABA-65599F9B4061Q42957045-44F8BDB4-7FF7-4A93-B902-6E83F66E094DQ43091154-37A97108-1C03-4BA4-93C4-1FCFBAF74DFDQ43825962-B2603A59-B4B0-4663-B90B-BC80FA3CBE04
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pilar Navarro
@ast
Pilar Navarro
@en
Pilar Navarro
@es
Pilar Navarro
@nl
Pilar Navarro
@sl
type
label
Pilar Navarro
@ast
Pilar Navarro
@en
Pilar Navarro
@es
Pilar Navarro
@nl
Pilar Navarro
@sl
prefLabel
Pilar Navarro
@ast
Pilar Navarro
@en
Pilar Navarro
@es
Pilar Navarro
@nl
Pilar Navarro
@sl
P1053
A-2122-2010
P106
P1153
56505655800
P21
P31
P3829
P496
0000-0003-4314-4584
P569
2000-01-01T00:00:00Z